期刊文献+

血清HE4和CA125联检在卵巢癌中的临床价值 被引量:3

下载PDF
导出
摘要 本文应用化学发光免疫定量分析法对100名正常健康女性、66例卵巢癌患者和62例卵巢良性疾病患者进行血清HE4和CA125测定,旨在探讨人附睾分泌蛋白4(HE4)和CA125联检在卵巢癌诊断中的临床应用价值和意义。
作者 郭继强
出处 《放射免疫学杂志》 CAS 2013年第5期697-698,共2页 Journal of Radioimmanology
  • 相关文献

参考文献7

  • 1Kirchhoff C, Habben I, Ivell R, et al. A major human epididym is specific cdna encodes a protein with sequence homology to extracellular proteinase inhibitors [J]. Biol Reprod, 1991,45 (2) :350-357.
  • 2Galgano MT, Hampton GM, Friersan HF Jr. Comprehensive analy- sis of HE4 expression in normal and malignant human tissues [J]. Mod- em Pathology, 2006, 19 (6) : 847-853.
  • 3Bingle L, Singleton V, Bingle CD. The putative ovarian turnout maker gene HE4 (WFDC2) , is expressed in normal tissues and under- goes complex alternative splicing to yield multiple protein isoforms [ J ]. Oneogene, 2002, 21 (17) : 2768-2773.
  • 4Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma [ J ]. Cancer Res, 2003, 63 (13) : 3695-3700.
  • 5Moore RG, Brown AK, Miller MC, et al. The use of multiple no- vel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass [J]. Gynecol Oncol, 2008, 108 (2) :402-408.
  • 6张欣,吴令英,李晓江,李洪君,张蓉,刘丽影.盆腔良性肿物伴血清CA_(125)水平升高的临床意义[J].中华妇产科杂志,2005,40(3):178-182. 被引量:65
  • 7Wang K, Gan L, Jeffrey E, et al. Monitoring gene expression pro- file changes in ovarian carcinom as using cDNA microarray [ J ] . Gene, 1999, 229:101-108.

二级参考文献14

  • 1周应芳,吴北生,李辉,郑淑蓉.CA_(125)测定对子宫肌腺病的诊断价值[J].中华妇产科杂志,1996,31(10):590-593. 被引量:73
  • 2连利娟.卵巢癌单克隆抗体在诊断上的应用[J].中华妇产科杂志,1985,20(5):257-257.
  • 3Milojkovic M, Hrgovic Z, Hrgovic I, et al. Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis. Arch Gynecol Obstet,2004 ,269 :176-180.
  • 4Bilgin T, Karabay A, Dolar E, et al. Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: a series of 10 cases.Int J Gynecol Cancer,2001,11:290-294.
  • 5Vieira SC, Pimentel LH, Ribeiro JC, et al. Meigs′ syndrome with elevated CA 125: case report.Sao Paulo Med J,2003, 121:210-212.
  • 6Abad A, Cazorla E, Ruiz F, et al. Meigs′ syndrome with elevated CA125: case report and review of the literature.Eur J Obstet Gynecol Reprod Biol, 1999, 82:97-99.
  • 7Patsner B. Meigs′ syndrome and “false positive” preoperative serum CA-125 levels: analysis of ten cases. Eur J Gynaecol Oncol, 2000,21:362-363.
  • 8Kobayashi H, Ida W, Terao T, et al. Molecular characteristics of the CA 125 antigen produced by human endometrial epithelial cells: comparison between eutopic and heterotopic epithelial cells.Am J Obstet Gynecol,1993,169:725-730.
  • 9McBean JH, Brumsted JR. In vitro CA-125 secretion by endometrium from women with advanced endometriosis.Fertil Steril,1993,59:89-92.
  • 10Barbieri RL. CA-125 in patients with endometriosis.Fertil Steril, 1986,45:767-769.

共引文献64

同被引文献22

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部